740P Olaparib maintenance monotherapy for non-germline BRCA1/2-mutated (non-gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC): Exploratory biomarker analyses of the phase IIIb OPINION study
| Autor: | Lindemann, K., Škof, E., Colombo, N., González-Martín, A., Davidson, R., Blakeley, C., Bennett, J., Barnicle, A., Poveda, A. |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S738-S739 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|